Allakos Inc. - stock earnings
ALLK Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -45.6 million USD | ? USD |
2023Q2 | -35.1 million USD | ? USD |
2023Q1 | -39.8 million USD | ? USD |
2022Q4 | -39.8 million USD | ? USD |
2022Q3 | -30.2 million USD | ? USD |
2022Q2 | -49.1 million USD | ? USD |
2022Q1 | -198.4 million USD | ? USD |
2021Q4 | -94.4 million USD | ? USD |
2021Q3 | -62.7 million USD | ? USD |
2021Q2 | -57.2 million USD | ? USD |
2021Q1 | -55.6 million USD | ? USD |
2020Q4 | -44.3 million USD | ? USD |
2020Q3 | -42.1 million USD | ? USD |
2020Q2 | -39.3 million USD | ? USD |
2020Q1 | -26.0 million USD | ? USD |
2019Q4 | -24.6 million USD | ? USD |
2019Q3 | -21.7 million USD | ? USD |
2019Q2 | -19.0 million USD | ? USD |
2019Q1 | -20.0 million USD | ? USD |
2018Q4 | -14.5 million USD | ? USD |
2018Q3 | -11.1 million USD | ? USD |
2018Q2 | -9.4 million USD | ? USD |
2018Q1 | -8.5 million USD | ? USD |
2017Q4 | -7.9 million USD | ? USD |
2017Q3 | -5.9 million USD | ? USD |
2017Q2 | -4.7 million USD | ? USD |
2017Q1 | -5.1 million USD | ? USD |
2016Q4 | -17.1 million USD | ? USD |
ALLK Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -166.1 million USD | ? USD |
2022 | -317.5 million USD | ? USD |
2021 | -267.2 million USD | ? USD |
2020 | -147.6 million USD | ? USD |
2019 | -77.7 million USD | ? USD |
2018 | -43.5 million USD | ? USD |
2017 | -23.6 million USD | ? USD |
2016 | -17.1 million USD | ? USD |
ALLK
Price: $1.10
52 week price:
Earnings Per Share: -2.14 USD
P/E Ratio: -0.80
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 140771
Market Capitalization: 105.4 million